HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use
Switzerland
14802730.3
Filed on 2014-10-22
14802730.3
Filed on 2014-10-22
HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use
Australia
2019203443
Filed on 2019-10-22
2019203443
Filed on 2019-10-22
Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor
Australia
2020220209
Filed on 2020-08-21
2020220209
Filed on 2020-08-21
CD8+ T CELLS THAT ALSO EXPRESS PD-1 AND/OR TIM-3 FOR THE
TREATMENT OF CANCER
Hong Kong
42020016957.1
Filed on 2020-09-28
42020016957.1
Filed on 2020-09-28
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Hong Kong
62020019700.7
Filed on 2020-11-09
62020019700.7
Filed on 2020-11-09
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Hong Kong
62020021274.9
Filed on 2020-11-30
62020021274.9
Filed on 2020-11-30
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
Hong Kong
62020013025.5
Filed on 2020-07-31
62020013025.5
Filed on 2020-07-31
METHODS OF ISOLATING T CELL POPULATIONS
Patent Cooperation Treaty
PCT/US2020/051548
Filed on 2020-09-18
PCT/US2020/051548
Filed on 2020-09-18
T CELL RECEPTORS SPECIFIC FOR MUTATED KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG
Saudi Arabia
520420365
Filed on 2020-10-15
520420365
Filed on 2020-10-15
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
European Patent
20192082.4
Filed on 2020-08-21
20192082.4
Filed on 2020-08-21